The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership – ...

Novo Nordisk has reached an agreement to buy Germany’s Cardior Pharmaceuticals for €1.025 billion ($1.1 billion), adding expertise in RNA therapeutics and a heart failure therapy in mid-stage trials.

Ever felt like your artistic soul was trapped in this mouse-clicking and touchpad world? Now is the time to break free into the exciting world of graphic tablets. These nifty little devices are the ...

Stop chasing the "magic pen." As a brand consultant, I've seen more bad ideas sketched with expensive tools than I care to count. The right pen isn't about price; it's about purpose. Here’s my ...